Australian Banks. Insolent Insolvencies

Similar documents
Australian Banks. Funding markets open for now

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

Healthcare. Currency adjustments AUSTRALIA. Event. Impact. Outlook COH 8.0% RMD 6.9% CSL 6.0% ANN 5.0% SHL 2.6%

Aussie Macro Moment. Budget 16/17 careful consolidation AUSTRALIA. Event. Impact. Outlook

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

Australian Mobile Market

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

National Australia Bank

Platinum Asset Management

Builders Barometer. Rising damp AUSTRALIA. Event. Impact. Outlook

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

US Economics. State of the Union Growth, rates, and equities NORTH AMERICA. In a nutshell. Our key views on growth, policy, and rates

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Auckland International Airport

Generation Healthcare REIT

Aust. General Insurance

National Australia Bank

Vista Group International

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Sims Metal Management

Automotive Holdings Group

Aventus Retail Property Fund

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Fisher & Paykel Healthcare

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Whitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.

Bendigo and Adelaide Bank

Genworth Mortgage Insurance Australia

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

The Carbon Tax. Macquarie Funds Group. Implications for the Economy AUSTRALIA. Event. Impact. Outlook. 11 July 2011

Bendigo and Adelaide Bank

Austal. Retail take up 62% Earnings and target price revision. Price catalyst. Action and recommendation

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Kingsgate Consolidated

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds.

European and UK economics

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Billabong International

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Australia Banks. A little ray of sunshine AUSTRALIA. Event. Impact. Outlook. 16 April 2013 Macquarie Securities (Australia) Limited

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Australia without mining

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Spotless Group Holdings

The quiet achiever. Earnings and target price revision. Price catalyst. Catalyst: July building approvals 30 August. Action and recommendation

Commodities Comment. PGM cost curve another difficult year for S. African miners GLOBAL. Feature article. Latest news

Commodities Comment. Xiongan A new city with new metals demand GLOBAL. Feature article. Latest news

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Iron Mountain. US$10 worth Recalling at investor day US$31.83 UNITED STATES. Event. Impact. Earnings and target price revision.

SingTel. Optus rises A$3.98 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

JB Hi-Fi & Harvey Norman

Senex Energy Production and revenue unsurprised, cash builds on lower capex

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Downer EDI Two out of three ain t bad Event

Generation Healthcare REIT All about spread Event

PanAust. Larger impairment and dividend cut A$1.35 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Coca-Cola Amatil. Earnings and target price revision. Price catalyst. Action and recommendation

APA Group. Earnings and target price revision. Price catalyst

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

Fortescue Metals Group

CSL: Global plasma report

NEW ZEALAND Price Valuation NZ$ 1.74 Event 12-month target NZ$ month TSR % -10.1

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Fisher & Paykel Healthcare

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Perseus Mining. Revised Sissingué plan A$0.31 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

ANZ Bank. Sticking with Super Regional A$27.52 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Super Retail Group (SUL AU) Are we there yet?

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Pilbara Minerals (PLS AU) Ramp-up gaining traction

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Weekly Market Action Thursday 9 June 2011 to Thursday 16 June 2011

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

QR National. Earnings and target price revision. Price catalyst. Action and recommendation

Genesis Energy. A 9% FCF yield and you call underperform? NZ$1.71 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Commodities Comment. Chinese steel sentiment extremely positive ahead of peak season GLOBAL. Feature article. Latest news

Adelaide Brighton. Overcoming headwinds A$5.45 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Commodities Comment. China Copper Survey: Demand picking up, sentiment remains positive GLOBAL. Feature article. Latest news

Earnings and target price revision. Price catalyst. Action and recommendation

Kiwi Property Group. Land banking for the future NZ$1.43 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Transcription:

AUSTRALIA Insolvencies Stubborn # of Insolvencies 17, 16, 15, 14, 13, 12, 11, 1, Source: ASIC, Macquarie Research, Dec 212 WA/VIC insolvencies deterioration 2.4 2.2 Jan- 2 1.8 1.6 1.4 1.2 1 Source: ASIC, Macquarie Research, Dec 212 Insolvencies diverging from BDDs 9 7 5 3 1 # of insolvencies yearly rolling (LHS) PcP growth (RHS) Linear (# of insolvencies yearly rolling (LHS)) Source: Bank Data, ASIC, Dec 212 12% 1% 8% 6% 4% 2% 11 December 212 Macquarie Securities (Australia) Limited % Jan-8 May-8 Sep-8 Jan-9 May-9 Sep-9 Jan-1 May-1 Sep-1 NSW VIC QLD SA WA 27 28 29 21 211 212 BDD Write-Offs Insolvencies (RHS) 1 155 15 145 1 135 13 125 1 115 11 Insolent Insolvencies Event Overlaying recent insolvency trends with the diverging BDD/write-off picture indicates that unless there is a substantial improvement in the economic outlook, impairment charges are likely to head up in FY13. Impact Insolvencies still stubbornly high - ASIC s insolvency monthly statistics showed continued weakness in corporate Australia. Whilst the monthly growth in insolvency appointments has not yet reached GFC highs, the sticky elevation and upward trending number of insolvencies is concerning. Driving the national insolvencies uptick were increases from the slowing of the highspeed WA economy, and the further deterioration in VIC economy. This data plays directly into the observations of materially weaker pre-commitment levels of new residential developments in Victoria. Insolvencies, similar to write-offs, are marching to a different beat than impairment charges As raised in our report Cash is King, 23 November, we highlighted the ongoing divergence between write-offs and the banks impairment charge. When overlaying ongoing insolvency trends, an interesting picture begins to emerge. Similar to write-offs, insolvencies increased around 29 and have stayed high, with a possible argument that they have actually increased post 21. This analysis would seem to indicate that unless insolvencies and write-offs take a material step down over the course of the next year, that impairment charges are due for an increase in FY13. Some cracks emerging we expect more to appear in FY13 - Asset quality across the majors showed signs of deterioration with BDD expenses flat to up and corporate credit quality showing some cracks, in November 212 reporting season. A common theme in reporting season was the deterioration of the Business and Institutional divisions, with HoH BDD expenses up 57% A (Business and ex. APEA divisions), CBA +6% (business) and +264%, NAB +4% business and WBC remained flat after large increases in BDD expenses in. We d expect this to continue in to next year, as the impact of the mining slowdown becomes more apparent. Outlook Coming out of Bank reporting season, BDD expenses on average were higher in for the sector. Concerning is the emergence of a corporate BDD cycle, with corporate asset quality deteriorating in (increasing impaired asset, past dues and BDD expenses). It is most likely that the deterioration seen to date will see higher BDD charges in 2H13; there is however a chance this uptick will be seen in 1H13 from banks with poorer quality books such as NAB. Please refer to the important disclosures and analyst certification on inside back cover of this document, or on our website www.macquarie.com/disclosures.

Assessing asset quality further deterioration in sight ASIC s insolvency monthly statistics showed continued weakness in corporate Australia in the latest data, October 212. Insolvencies ticked up MOM. Whilst the monthly growth in insolvency appointments has not yet reached GFC highs, the sticky elevation and upward trending number of insolvencies is concerning. Fig 1 Australian insolvencies, sticky elevated and upward trending insolvency numbers # of Insolvencies 17, 16, 15, 14, 13, 12, 11, 1, Jul-4 Nov-4 Mar-5 Jul-5 Nov-5 Source: ASIC, Macquarie Research, December 212 y = 51.62x - 5413 Mar-6 Jul-6 Nov-6 Mar-7 Jul-7 Nov-7 Mar-8 Jul-8 Nov-8 Mar-9 Jul-9 Nov-9 Mar-1 Jul-1 Nov-1 Mar-11 # of insolvencies yearly rolling (LHS) PcP growth (RHS) Linear (# of insolvencies yearly rolling (LHS)) Jul-11 Nov-11 Mar-12 Jul-12 Driving the national insolvencies uptick were increases from the slowing of the high-speed WA economy, and the further deterioration in VIC economy. This data plays directly into the observations of materially weaker pre-commitment levels of new residential developments in Victoria. 7% 6% 5% 4% 3% 2% 1% % -1% -2% -3% Fig 2 State by State Insolvencies Levels remain high Fig 3 State by State Indexed Insolvencies Some signs of an uptick 7,8 1,2 2.4 6,8 5,8 4,8 3,8 2,8 1,8 Jan-8 May-8 Sep-8 Jan-9 May-9 Sep-9 Jan-1 May-1 Sep-1 NSW VIC QLD SA (RHS) WA (RHS) Source: ASIC, Macquarie Research, December 212 Source: ASIC, Macquarie Research, December 212 1, 8 6 4 2 NSW and QLD also showed signs of deterioration, with October insolvencies ticking up. Whilst by no means peak monthly growth for 212, the states insolvency levels continue to tick up and remain stuck at elevated levels. 2.2 2 1.8 1.6 1.4 1.2 1 Jan-8 May-8 Sep-8 Jan-9 May-9 Sep-9 Jan-1 May-1 Sep-1 NSW VIC QLD SA WA 11 December 212 2

More concerning Impairment bucking write-off/insolvencies trends As raised in our report Cash is King, we highlighted the ongoing divergence between write-offs and the banks impairment charge. When overlaying ongoing insolvency trends an interesting picture begins to emerge. Similar to write-offs, insolvencies increased around 29 and have stayed high, with a possible argument that they have actually increased. Fig 4 BDDs, write-offs and insolvencies trend heading the wrong way 1 1 27 28 29 21 211 212 Impairment Charge Write-Offs Insolvencies (RHS) 1 155 15 145 1 135 13 125 1 115 11 Source: Bank Data, ASIC, Macquarie Research, December 212 This trend is exacerbated further when removing NAB, where the impairment charge has been substantially higher than the other banks due to ongoing issues in the UK. Fig 5 BDDs, write-offs and insolvencies (ex NAB) trend exacerbated 9 7 5 3 1 27 28 29 21 211 212 BDD Write-Offs Insolvencies (RHS) 1 155 15 145 1 135 13 125 1 115 11 Source: ASIC, Company data, Macquarie Research, December 212 This overall analysis would seem to indicate that unless insolvencies and write-offs take a material step down over the course of the next year, that impairment charges are due for an increase. 11 December 212 3

Given asset quality deteriorated in reporting season, the read-through from the Insolvency data suggests further BDD hits are likely in FY13 Asset quality across the majors showed signs of deterioration with BDD expenses flat to up and corporate credit quality showing some cracks, in November 212 reporting season. A common theme in reporting season was the deterioration of the Business and Institutional divisions, with HoH BDD expenses up 57% A (Business and ex. APEA divisions), CBA +6% (business) and +264%, NAB +4% business and WBC remained flat after large increases in BDD expenses in. Given the continued deterioration of business credit quality in October 212 as reflected in ASIC data, we reiterate our sector macro call, where we remain comfortably cautious on asset quality in the sector and confirm our 2H13/1H14 BDD cycle. Fig 6 A BDD expense uptick driven by Business and divisions Fig 7 CBA reduction in retail BDD expense offset by increase in 75 6 7 65 6 55 5 45 63-15 564 549 549 75-2 61 61 4-8 686 681 681 55 5 45 4 35 545-17 7 87 438 438 445 15-15 -12 532 532 531 531 543 4 3 Business Banking APEA ex. APEA Business Banking Bank West Source: Company data, Macquarie Research, December 212 Source: Company data, Macquarie Research, December 212 Fig 8 NAB - reduction in retail BDD expense offset by increase in Business, UK and provision Top-Up 1,7 Fig 9 WBC flat BDD expenses driven by reduction in St. George BDD exp, and increases in other divisions 65 1,5 1,3 1,1 9 7 1,131-96 149 1,35 1,35 17-27 2 24 1,157 1,157 1,159 1,183 193 1,291 1,484 6 55 5 45-7 68 61-47 67-3 -11-3 554 551 54 537 537 64 5 4 3 Business UK & Business St.George Source: Company data, Macquarie Research, December 212 Source: Company data, Macquarie Research, December 212 11 December 212 4

Important disclosures: Recommendation definitions Macquarie - Australia/New Zealand Outperform return >3% in excess of benchmark return Neutral return within 3% of benchmark return Underperform return >3% below benchmark return Benchmark return is determined by long term nominal GDP growth plus 12 month forward market dividend yield Macquarie Asia/Europe Outperform expected return >+1% Neutral expected return from -1% to +1% Underperform expected return <-1% Macquarie First South - South Africa Outperform expected return >+1% Neutral expected return from -1% to +1% Underperform expected return <-1% Macquarie - Canada Outperform return >5% in excess of benchmark return Neutral return within 5% of benchmark return Underperform return >5% below benchmark return Macquarie - USA Outperform (Buy) return >5% in excess of Russell 3 index return Neutral (Hold) return within 5% of Russell 3 index return Underperform (Sell) return >5% below Russell 3 index return Volatility index definition* This is calculated from the volatility of historical price movements. Very high highest risk Stock should be expected to move up or down 6 1% in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least 4 6% in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least 3 4% in a year. Low medium stock should be expected to move up or down at least 25 3% in a year. Low stock should be expected to move up or down at least 15 25% in a year. * Applicable to Australian//Canada stocks only Recommendations 12 months Note: Quant recommendations may differ from Fundamental Analyst recommendations Financial definitions All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/ listed stocks are modelled under IFRS (International Financial Reporting Standards). Recommendation proportions For quarter ending 3 Sept 212 AU/ Asia RSA USA CA EUR Outperform 5.% 56.85% 61.54% 41.38% 63.19% 44.15% (for US coverage by MCUSA, 7.35% of stocks covered are investment banking clients) Neutral 36.62% 25.14% 27.69% 52.13% 3.77% 3.57% (for US coverage by MCUSA, 9.31% of stocks covered are investment banking clients) Underperform 13.38% 18.2% 1.77% 6.49% 6.4% 25.28% (for US coverage by MCUSA,.% of stocks covered are investment banking clients) Company Specific Disclosures: Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures. Analyst Certification: The views expressed in this research reflect the personal views of the analyst(s) about the subject securities or issuers and no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research receives compensation based on overall revenues of Macquarie Group Ltd (ABN 94 122 169 279, AFSL No. 31862) ( MGL ) and its related entities (the Macquarie Group ) and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. General Disclosure: This research has been issued by Macquarie Securities (Australia) Limited (ABN 58 2 832 126, AFSL No. 238947) a Participant of the Australian Securities Exchange (ASX) and Chi-X Australia Pty Limited. This research is distributed in Australia by Macquarie Equities Limited (ABN 41 2 574 923, AFSL No. 23754) ("MEL"), a Participant of the ASX, and in New Zealand by Macquarie Equities New Zealand Limited ( ME ) an X Firm. s services in New Zealand are provided by ME. Macquarie Bank Limited (ABN 46 8 583 542, AFSL No. 23752) ( MBL ) is a company incorporated in Australia and authorised under the Banking Act 1959 (Australia) to conduct banking business in Australia. None of MBL, MGL or ME is registered as a bank in New Zealand by the Reserve Bank of New Zealand under the Reserve Bank of New Zealand Act 1989. Any MGL subsidiary noted in this research, apart from MBL, is not an authorised deposit-taking institution for the purposes of the Banking Act 1959 (Australia) and that subsidiary s obligations do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of that subsidiary, unless noted otherwise. This research is general advice and does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision. This research has been prepared for the use of the clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient, you must not use or disclose this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. This research is based on information obtained from sources believed to be reliable, but the Macquarie Group does not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. The Macquarie Group accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. The Macquarie Group produces a variety of research products, recommendations contained in one type of research product may differ from recommendations contained in other types of research. The Macquarie Group has established and implemented a conflicts policy at group level, which may be revised and updated from time to time, pursuant to regulatory requirements; which sets out how we must seek to identify and manage all material conflicts of interest. The Macquarie Group, its officers and employees may have conflicting roles in the financial products referred to in this research and, as such, may effect transactions which are not consistent with the recommendations (if any) in this research. The Macquarie Group may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case. The Macquarie Group s employees or officers may provide oral or written opinions to its clients which are contrary to the opinions expressed in this research. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures. 11 December 212 5